---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-179892"
form_type: "8-K"
ticker: "RPRX"
cik: "0001802768"
company_name: "Royalty Pharma plc"
filed_at: "2025-08-13T23:59:59+00:00"
generated_at: "2026-05-17T13:58:32.226934+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Henry Fernandez steps down as Lead Independent Director of Royalty Pharma board

## Summary
- Fernandez resigned effective August 13, 2025, after five years on the board.
- No disagreement with the company; departure is voluntary.
- Board thanks Fernandez for his service and contributions.
- Company intends to name a new Lead Independent Director in the near future.

## SEC filing metadata
- accession: 0001193125-25-179892
- form_type: 8-K
- ticker: RPRX
- cik: 0001802768
- company_name: Royalty Pharma plc
- filed_at: 2025-08-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802768/000119312525179892/0001193125-25-179892-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802768/000119312525179892/d930454d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-179892
- JSON: https://secwatch.observer/filing/0001193125-25-179892.json
- Plain text: https://secwatch.observer/filing/0001193125-25-179892.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.